Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
- 12 September 1998
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 352 (9131), 837-853
- https://doi.org/10.1016/s0140-6736(98)07019-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen StudyDiabetes Care, 1998
- United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- Potassium channels in the cardiovascular systemDiabetes Research and Clinical Practice, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Cardiovascular effects of sulphonylurea derivativesDiabetologia, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yearsJournal of Internal Medicine, 1991
- Hyperglycaemia and coronary heart disease: The Whitehall StudyJournal of Chronic Diseases, 1979
- Effects of Hypoglycemic Agents on Vascular Complications in Patients With Adult-Onset DiabetesJAMA, 1978
- A Study of the Effects of Hypoglycemic Agents on Vascular Complications in Patients with Adult-onset Diabetes: VI. Supplementary Report on Nonfatal Events in Patients Treated with TolbutamideDiabetes, 1976